133 related articles for article (PubMed ID: 21109080)
21. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
23. In vitro 1H MR spectroscopy of squamous cell carcinoma of the extracranial head and neck.
Mukherji SK; Gerstle RJ
Neuroimaging Clin N Am; 1998 Nov; 8(4):835-47. PubMed ID: 9769345
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
[TBL] [Abstract][Full Text] [Related]
25. Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region.
Mandic R; Eikelkamp N; Peldszus R; Sadowski M; Sesterhenn AM; Dünne AA; Werner JA
Anticancer Res; 2001; 21(5):3413-8. PubMed ID: 11848502
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
27. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
Lim SC; Park SY; Do NY
Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
[TBL] [Abstract][Full Text] [Related]
28. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
[TBL] [Abstract][Full Text] [Related]
29. Nucleostemin expression in squamous cell carcinoma of the head and neck.
Cada Z; Boucek J; Dvoranková B; Chovanec M; Plzák J; Kodets R; Betka J; Pinot GL; Gabius HJ; Smetana K
Anticancer Res; 2007; 27(5A):3279-84. PubMed ID: 17970071
[TBL] [Abstract][Full Text] [Related]
30. [Computerized tomography and magnetic resonance tomography in head-neck tumors. Methods, chief criteria, differential diagnosis and clinical results].
Lenz M
Fortschr Geb Rontgenstrahlen Neuen Bildgeb Verfahr Erganzungsbd; 1992; 130():1-199. PubMed ID: 1339587
[No Abstract] [Full Text] [Related]
31. RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma.
Brunner M; Erovic B; Heiduschka G; Schneider S; Pammer J; Frantal S; Thurnher D
Eur Surg Res; 2010; 44(3-4):214-9. PubMed ID: 20571277
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.
Smith BD; Haffty BG
Radiat Oncol Investig; 1999; 7(3):125-44. PubMed ID: 10406054
[TBL] [Abstract][Full Text] [Related]
33. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
Grandis JR; Tweardy DJ
Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
[TBL] [Abstract][Full Text] [Related]
34. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
Lee KD; Lee HS; Jeon CH
Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
[TBL] [Abstract][Full Text] [Related]
35. Nuclear mechanisms for the increase of epidermal growth factor receptor in squamous cell carcinoma.
Hendler FJ; Richards CS; Shum A; Burns D; Schaefer S; Ozanne B
Trans Assoc Am Physicians; 1985; 98():189-97. PubMed ID: 3842196
[No Abstract] [Full Text] [Related]
36. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
37. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
38. Validation of tissue array technology in head and neck squamous cell carcinoma.
Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
[TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma.
Shores CG; Yin X; Funkhouser W; Yarbrough W
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):937-42. PubMed ID: 15313863
[TBL] [Abstract][Full Text] [Related]
40. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
